IMCC
IMCC
NASDAQ · Pharmaceuticals

Im Cannabis Corp

$0.57
-0.03 (-5.09%)
As of Mar 25, 5:31 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +522.0% upside
Low Target $2.21
Average Target $3.54
High Target $4.26
Current Price $0.57
Current
$0.57
Target
$3.54
$2.21 $3.54 avg $4.26
Scenario Analysis
Bear Case
$2.21
288.3%
Low target
Base Case
$3.54
+522.0%
Avg target
Bull Case
$4.26
+648.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$9.70
-94.1% from high
52-Week Low
$1.75
+-67.5% from low
Target vs 52W High
$3.54
-63.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%